Stay updated on Nivolumab in IDH-Mutant Gliomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.

Latest updates to the Nivolumab in IDH-Mutant Gliomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.2%
- Check19 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.2%
- Check62 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed background information on gliomas and the drug nivolumab, while adding a new version revision and a mention of the study's location.SummaryDifference56%
- Check69 days agoChange DetectedThe page has been updated to reflect a change from a recruiting status to an active status, and several specific dates have been modified or removed, indicating a shift in the timeline of events.SummaryDifference3%
Stay in the know with updates to Nivolumab in IDH-Mutant Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.